Before giving pantoprazole to patients with gastric ulcers the possibility of malignancy should be considered since the drug may mask symptoms and delay diagnosis. Pantoprazole should be used with caution in hepatic impairment because an increase in pantoprazole bioavailability and elimination half-life has been reported.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
